Cargando…

Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC

INTRODUCTION: RNA editing, a wide-acknowledged post-transcriptional mechanism, has been reported to be involved in the occurrence and development of cancer, especially the abnormal alteration of adenosine to inosine. However, fewer studies focus on pancreaticcancer. Therefore, we aimed to explore th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Yue, Liang, Dong, Ai, Bin, Wang, Tengjiao, Guo, Shiwei, Jin, Gang, Yu, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990869/ https://www.ncbi.nlm.nih.gov/pubmed/36895481 http://dx.doi.org/10.3389/fonc.2023.1092046

Ejemplares similares

The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data
por: Yu, Dong, et al.
Publicado: (2021)

The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation
por: Liu, Chao, et al.
Publicado: (2023)

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
por: Dai, Manxiong, et al.
Publicado: (2022)

A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis
por: Zhang, Leiming, et al.
Publicado: (2023)

The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
por: Anu, R. I., et al.
Publicado: (2023)

The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies
por: Perez, Vincent M., et al.
Publicado: (2021)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
por: Wang, Heming, et al.
Publicado: (2021)

Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
por: Li, Qian, et al.
Publicado: (2022)

Genome-wide identification and analysis of A-to-I RNA editing events in bovine by transcriptome sequencing
por: Bakhtiarizadeh, Mohammad Reza, et al.
Publicado: (2018)

Genome-Wide Identification and Analysis of the Methylation of lncRNAs and Prognostic Implications in the Glioma
por: He, Yijie, et al.
Publicado: (2021)

Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019)

Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level
por: Zimmermann, Michael T., et al.
Publicado: (2021)

Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
por: Zhou, Chi, et al.
Publicado: (2020)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

Uncovering the special microbiota associated with occurrence and progression of gastric cancer by using RNA-sequencing
por: Ai, Bin, et al.
Publicado: (2023)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells
por: Mijit, Mahmut, et al.
Publicado: (2022)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC
por: Xie, Yongjie, et al.
Publicado: (2022)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC
por: Cattolico, Carlotta, et al.
Publicado: (2022)

The Integration of the Pre-Treatment Neutrophil-to-Lymphocyte Ratio in the Eighth Edition of the AJCC Staging System for Nasopharynx Cancer
por: Liang, Zhong-Guo, et al.
Publicado: (2021)

Immune-related somatic mutation genes are enriched in PDACs with diabetes
por: Wang, Kaixuan, et al.
Publicado: (2019)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Genome-Wide Identification of U-To-C RNA Editing Events for Nuclear Genes in Arabidopsis thaliana
por: Ruchika,, et al.
Publicado: (2021)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma
por: Chen, Juan, et al.
Publicado: (2020)

Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib
por: Wang, Yu, et al.
Publicado: (2021)

RBFOX2: a key factor in suppressing PDAC metastasis through regulation of alternative splicing events
por: Urbach, Laura, et al.
Publicado: (2023)

LINC00324 in cancer: Regulatory and therapeutic implications
por: Xia, Qing, et al.
Publicado: (2022)

Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients
por: Guo, Shiwei, et al.
Publicado: (2020)

In Silico analyses of host immunity and stroma provide prognostic factors in early stage pancreatic ductal adenocarcinoma (PDAC)
por: Williams, Madison H., et al.
Publicado: (2020)

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022)

Combatting PDAC with two tumor-targeting small RNAs
por: Kasinski, Andrea L.
Publicado: (2019)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Malinova, Antonia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_basfdvf53i9vtgs56qa9nvhpc0